Abstract Details

Title Peginterferon Beta-1a Treatment Reduces the Impact of Multiple Sclerosis Relapse and Disability Progression on Health-Related Quality of Life: Results from the ADVANCE Trial

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 177

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Elizabeth T. Kinter, PhD (Biogen Ided) PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Glenn A. Phillips, PhD	Dr. Phillips has received personal compensation for serving as an employee of argenx. Dr. Phillips has stock in argenx.
	No disclosure on file
Bjorn K. Sperling, MD	No disclosure on file

�鶹��ýӳ��

�鶹��ýӳ��

Abstract Details